Published in Cancer Weekly, May 6th, 2008
"Sources of data: This review focuses on the mechanism of action of the DNA repair protein, O-6-methylguanine-DNA methyltransferase (MGMT) and its exploitation in cancer therapy and reviews the current literature. Areas of agreement: MGMT can provide resistance to alkylating agents by DNA damage reversal. Inhibition of tumour...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.